Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis

References

• BarnesPJChronic obstructive pulmonary disease: a growing but neglected global epidemicPLoS Med20074e11217503959
   PubMed Web of Science ®Google Scholar
• ZhengJYangLWuYThe efficacy and safety of combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation twice daily via accuhaler in Chinese patients with COPDChest20071321756176317951625
   PubMed Web of Science ®Google Scholar
• RennardSTashkinDMcElhattanJGoldmanMRamachandranSEfficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trialDrugs20096954956519368417
   PubMed Web of Science ®Google Scholar
• LapperreTSnoeck-StrobandJGosmanMEffect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trialAnn Intern Med200915151752719841453
   PubMed Web of Science ®Google Scholar
• TashkinDPearleJIezzoniDVargheseSFormoterol and tiotropium compared with tiotropium alone for treatment of COPDCOPD20096172519229704
   PubMedGoogle Scholar
• CalverleyPRabeKGoehringURoflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trialsLancet200937468569419716960
   PubMed Web of Science ®Google Scholar
• FabbriLCalverleyPIzquierdo-AlonsoJRoflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trialsLancet200937469570319716961
   PubMed Web of Science ®Google Scholar
• RabeKBatemanEO’DonnellDRoflumilast – an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trialLancet200536656357116099292
   PubMed Web of Science ®Google Scholar
• CalverleyPSanchez-TorilFMcIvorAEffect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200717615416117463412
   PubMed Web of Science ®Google Scholar
• SinDDMcAlisterFAManSFAnthonisenNRContemporary management of chronic obstructive pulmonary disease: scientific reviewJAMA20032902301231214600189
   PubMed Web of Science ®Google Scholar
• SobierajDMWhiteCMColemanCIBenefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysisClin Ther2008301416142518803985
   PubMed Web of Science ®Google Scholar
• NanniniLCatesCLassersonTPoolePCombined corticoster- oid and long-acting beta-agonist in one inhaler versus pla- cebo for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20074CD00379417943798
   PubMed Web of Science ®Google Scholar
• YangIAFongKMSimEHBlackPNLassersonTJInhaled corticosteroids for stable chronic obstructive pulmonary diseaseCochrane Database Syst Rev20072CD00299117443520
   PubMed Web of Science ®Google Scholar
• WiltTJNiewoehnerDMacdonaldRKaneRLManagement of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guidelineAnn Intern Med200714763965317975187
   PubMed Web of Science ®Google Scholar
• NanniniLCatesCLassersonTPoolePCombined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20074CD00682917943918
   PubMed Web of Science ®Google Scholar
• NanniniLCatesCLassersonTPoolePCombined corticoster- oid and long-acting beta-agonist in one inhaler versus inhaled steroids for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20074CD00682617943917
   PubMed Web of Science ®Google Scholar
• PuhanMBachmannLKleijnenJTer RietGKessellsAInhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysisBMC Med20097219144173
   PubMed Web of Science ®Google Scholar
• BakerWBakerEColemanCPharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysisPharmacotherapy20092989190519637942
   PubMed Web of Science ®Google Scholar
• AaronSDFergussonDMarksGBfor the Canadian Thoracic Society/Canadian Respiratory Clinical Research ConsortiumCounting, analysing and reporting exacerbations of COPD in randomised controlled trialsThorax20086312212817702790
   PubMed Web of Science ®Google Scholar
• SuissaSStatistical treatment of exacerbations in therapeutic trials of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200617384284616439716
   PubMed Web of Science ®Google Scholar
• American Thoracic Society, European Respiratory SocietyStandards for the diagnosis and management of patients with COPD Available from: http://www.thoracic.org/clinical/copd-guidelines/resources/copddoc.pdf. Accessed January 10, 2011.
   Google Scholar
• Rodriguez-RoisinRToward a consensus definition for COPD exacerbationsChest2000117398S401S10843984
   PubMed Web of Science ®Google Scholar
• SalantiGKavvouraFKIoannidisJPExploring the geometry of treatment networksAnn Intern Med200814854455318378949
   PubMed Web of Science ®Google Scholar
• LuGAdesAECombination of direct and indirect evidence in mixed treatment comparisonsStat Med2004233105312415449338
   PubMed Web of Science ®Google Scholar
• SuttonAAdesAECooperNAbramsKUse of indirect and mixed treatment comparisons for technology assessmentPharmacoeconomics20082675376718767896
   PubMed Web of Science ®Google Scholar
• CooperNJSuttonAJLuGKhuntiKMixed comparison of stroke prevention treatments in individuals with nonrheumatic atrial fibrillationArch Intern Med20061661269127516801509
   PubMed Web of Science ®Google Scholar
• RennardSICalverleyPMGoehringUMBredenbrokerDMartinezFJReduction of exacerbations by the PDE4 inhibitor roflumilast – the importance of defining different subsets of patients with COPDRespir Res2011121821272339
   PubMed Web of Science ®Google Scholar
• WeltonNJCaldwellDMAdamopoulosEVedharaKMixed treatment comparison meta-analysis of complex interventions: psychological interventions in coronary heart diseaseAm J Epidemiol20091691158116519258485
   PubMed Web of Science ®Google Scholar
• SpiegelhalterDJBestNGCarlinBPvan der LindeABayesian measures of model compexity and fitJournal of the Royal Statistical Society200264583639
   Google Scholar
• DerSimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials198671771883802833
   PubMed Web of Science ®Google Scholar
• AaronSVandemheenKFergussonDTiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trialAnn Intern Med200714654555517310045
   PubMed Web of Science ®Google Scholar
• AnzuetoAFergusonGFeldmanGEffect of fluticasone propionate/salmeterol (250/50) on COPD exacerbations and impact on patient outcomesCOPD2009632032919863361
   PubMedGoogle Scholar
• BourbeauJRouleauMBoucherSRandomised controlled trial of inhaled corticosteroids in patients with chronic obstructive pulmonary diseaseThorax1998534774829713447
   PubMed Web of Science ®Google Scholar
• BrusascoVHodderRMiravitllesMHealth outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPDThorax20035839940412728159
   PubMed Web of Science ®Google Scholar
• BurgePCalverleyPJonesPRandomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trialBMJ20003201297130310807619
   PubMed Web of Science ®Google Scholar
• CalverleyPAndersonJCelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med200735677578917314337
   PubMed Web of Science ®Google Scholar
• CalverleyPBoonsawatWCsekeZMaintenance therapy with Budesonide and Formoterol in chronic obstructive pulmonary diseaseEur Respir J20032291291914680078
   PubMed Web of Science ®Google Scholar
• CalverleyPPauwelsRVestboJCombined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trialLancet200336144945612583942
   PubMed Web of Science ®Google Scholar
• CasaburiRMahlerDJonesPA long-term evaluation of once-daily inhaled Tiotropium in chronic obstructive pulmonary diseaseEur Respir J20021921722411866001
   PubMed Web of Science ®Google Scholar
• ChanCMaltaisFSigouinCA randomized controlled trial to assess the efficacy of Tiotropium in Canadian patients with chronic obstructive pulmonary diseaseCan Respir J20071446547218060091
   PubMed Web of Science ®Google Scholar
• ChapmanKArvidssonPChuchalinAThe addition of salmeterol 50 microg bid to anticholinergic treatment in patients with COPD: a randomized, placebo controlled trial. Chronic obstructive pulmonary diseaseCan Respir J2002917818512068339
   PubMedGoogle Scholar
• DusserDBravoMIaconoPThe effect of tiotropium on exacerbations and airflow in patients with COPDEur Respir J20062754755516507855
   PubMed Web of Science ®Google Scholar
• FergusonGAnzuetoAFeiREffect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbationsRespir Med20081021099110818614347
   PubMed Web of Science ®Google Scholar
• KardosPWenckerMGlaabTVogelmeierCImpact of Salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200717514414917053207
   PubMed Web of Science ®Google Scholar
• NiewoehnerDRiceKCoteCPrevention of exacerbations of chronic obstructive pulmonary disease with Tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trialAnn Intern Med200514331732616144890
   PubMed Web of Science ®Google Scholar
• PaggiaroPDahleRBakranIMulticentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study GroupLancet19983517737809519948
   PubMed Web of Science ®Google Scholar
• PowrieDWilkinsonTDonaldsonGEffect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPDEur Respir J20073047247817504798
   PubMed Web of Science ®Google Scholar
• StockleyRChopraNRiceLAddition of salmeterol to existing treatment in patients with COPD: a 12 month studyThorax20066112212816443706
   PubMed Web of Science ®Google Scholar
• SzafranskiWCukierARamirezAEfficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary diseaseEur Respir J200321748112570112
   PubMed Web of Science ®Google Scholar
• TashkinDCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med20083591543155418836213
   PubMed Web of Science ®Google Scholar
• TonnelAPerezTGrosboisJEffect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPDInt J Chron Obstruct Pulmon Dis2008330131018686739
   PubMedGoogle Scholar
• VogelmeierCKardosPHarariSFormoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month studyRespir Med20081021511152018804362
   PubMed Web of Science ®Google Scholar
• WedzichaJCalverleyPSeemungalTThe prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromideAm J Respir Crit Care Med2008177192617916806
   PubMed Web of Science ®Google Scholar
• RossiAKristufekPLevineBComparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPDChest20021211058106911948033
   PubMed Web of Science ®Google Scholar
• BakerWBakerEColemanCPharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysisPharmacotherapy20092989190519637942
   PubMed Web of Science ®Google Scholar
• BarnesNQiuYPavordIAnti-inflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung diseaseAm J Respir Crit Care Med200617373674316424444
   PubMed Web of Science ®Google Scholar
• BaumgartnerRHananiaNCalhounWNebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trialClin Ther20072926127817472819
   PubMed Web of Science ®Google Scholar
• BeehKBeierJBuhlREfficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severitiesPneumologie20066034134616761228
   PubMedGoogle Scholar
• BoydGMoriceAPounsfordMAn evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD)Eur Respir J1997108158219150318
   PubMed Web of Science ®Google Scholar
• CalverleyPLeeATowseLEffect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary diseaseThorax20035885586014514937
   PubMed Web of Science ®Google Scholar
• CampbellMElirazAJohanssonGFormoterol for maintenance and as-needed treatment of chronic obstructive pulmonary diseaseRespir Med2005991511152016199148
   PubMed Web of Science ®Google Scholar
• CasaburiRBriggsDJrDonohueJThe spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study GroupChest20001181294130211083677
   PubMed Web of Science ®Google Scholar
• CelliBHalpinDHepburnRSymptoms are an important outcome in chronic obstructive pulmonary disease clinical trials: results of a 3-month comparative study using the Breathlessness, Cough and Sputum Scale (BCSS)Respir Med200397S35S4312564609
   PubMed Web of Science ®Google Scholar
• CovelliHBhattacharyaSCassinoCConoscentiCKestenSAbsence of electrocardiographic findings and improved function with once-daily tiotropium in patients with chronic obstructive pulmonary diseasePharmacotherapy2005251708171816305289
   PubMed Web of Science ®Google Scholar
• DahlRGreefhorstLNowakDInhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200116477878411549532
   PubMed Web of Science ®Google Scholar
• Dal NegroRPomariCTognellaSMichelettoCSalmeterol and fluticasone 50 microg/250 microg bid in combination provides a better long-term control than salmeterol 50 microg bid alone and placebo in COPD patients already treated with theophyllinePulm Pharmacol Ther20031624124612850128
   PubMed Web of Science ®Google Scholar
• FreemanDLeeAPriceDEfficacy and safety of tiotropium in COPD patients in primary care – the SPiRiva Usual CarE (SPRUCE) studyRespir Res200784517605774
   PubMed Web of Science ®Google Scholar
• HananiaNDarkenPHorstmanDThe efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPDChest200312483484312970006
   PubMed Web of Science ®Google Scholar
• HattotuwaKGizyckiMAnsariTJefferyPBarnesNThe effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy studyAm J Respi Crit Care Med200216515921596
   PubMed Web of Science ®Google Scholar
• LittnerMIlowiteJTashkinDLong-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20001611136114210764302
   PubMed Web of Science ®Google Scholar
• Llewellyn-JonesCHarrisTStockleyREffect of fluticasone propionate on sputum of patients with chronic bronchitis and emphysemaAm J Respir Crit Care Med19961536166218564107
   PubMed Web of Science ®Google Scholar
• MahlerDDonohueJBarbeeREfficacy of salmeterol xinafoate in the treatment of COPDChest199911595796510208192
   PubMed Web of Science ®Google Scholar
• MahlerDWirePHorstmanDEffectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20021661084109112379552
   PubMed Web of Science ®Google Scholar
• O’DonnellDFlugeTGerkenFEffects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPDEur Respir J20042383284015218994
   PubMed Web of Science ®Google Scholar
• O’DonnellDSciurbaFCelliBEffect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPDChest200613064765616963658
   PubMed Web of Science ®Google Scholar
• PaggiaroPVagagginiBDi FrancoAEfficacy of nebulized flunisolide combined with salbutamol and ipratropium bromide in stable patients with moderate-to-severe chronic obstructive pulmonary diseaseRespiration20067360360916293958
   PubMed Web of Science ®Google Scholar
• RennardSAndersonWZuWallackRUse of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20011631087109211316640
   PubMed Web of Science ®Google Scholar
• Van der ValkPMonninkhofEvan der PalenJZielhuisGvan HerwaardenCEffect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE studyAm J Respir Crit Care Med20021661358136312406823
   PubMed Web of Science ®Google Scholar
• Van NoordJAumannJJanssensEComparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPDEur Respir J20052621422216055868
   PubMed Web of Science ®Google Scholar
• Van NoordJde MunckDBantjeTLong-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropiumEur Respir J20001587888510853852
   PubMed Web of Science ®Google Scholar
• VerkindreCBartFAguilaniuBThe effect of tiotropium on hyperinflation and exercise capacity in chronic obstructive pulmonary diseaseRespiration20067342042716484769
   PubMed Web of Science ®Google Scholar
• WadboMLöfdahlCLarssonKEffects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled studyEur Respir J2002201138114612449166
   PubMed Web of Science ®Google Scholar
• WeirDBaleGBrightPBurgePA double-blind placebo-controlled study of the effect of inhaled beclomethasone dipropionate for 2 years in patients with nonasthmatic chronic obstructive pulmonary diseaseClin Exp Allergy19992912512810421835
   PubMed Web of Science ®Google Scholar
• DonohueJvan NoordJBatemanEA 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterolChest2002122475512114338
   PubMed Web of Science ®Google Scholar
• MoayyediPMeta-analysis: Can we mix apples and oranges?Am J Gastroenterol2004992297230115571572
   PubMed Web of Science ®Google Scholar
• HigginsJPWhiteheadABorrowing strength from external trials in a meta-analysisStat Med199615273327498981683
   PubMed Web of Science ®Google Scholar